|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-5-6
|
|
pubmed:abstractText |
A 65-year-old male with lung adenocarcinoma received radiotherapy to the mediastinum and right upper lobe, followed by chemotherapy with gemcitabine. Radiation recall dermatitis developed in the area corresponding to the radiotherapy portal. This is one of just a few cases reported recently concerning radiation recall dermatitis stemming from gemcitabine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
428-30
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:11989599-Adenocarcinoma,
pubmed-meshheading:11989599-Aged,
pubmed-meshheading:11989599-Antimetabolites, Antineoplastic,
pubmed-meshheading:11989599-Chemotherapy, Adjuvant,
pubmed-meshheading:11989599-Deoxycytidine,
pubmed-meshheading:11989599-Humans,
pubmed-meshheading:11989599-Lung Neoplasms,
pubmed-meshheading:11989599-Male,
pubmed-meshheading:11989599-Mental Recall,
pubmed-meshheading:11989599-Radiation-Sensitizing Agents,
pubmed-meshheading:11989599-Radiodermatitis,
pubmed-meshheading:11989599-Radiotherapy, Adjuvant,
pubmed-meshheading:11989599-Skin
|
|
pubmed:articleTitle |
Gemcitabine-induced radiation recall dermatitis: case report.
|
|
pubmed:affiliation |
Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa. bar_sela@rambam.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
